Other studies have shown that blocking the activation of epidermal growth factor receptor (EGFR) can inhibit the infiltration and oxidative stress of kidney immune cells, increase islet autophagy activity, and improve diabetic nephropathy (Li et al., 2018). Here, EGFR is linked to diabetic kidney disease.